STAAR Surgical Q1 net sales up 119.6% to $93.5M; returns to profitability with GAAP EPS $0.10

STAAR SURGICAL CO

2026-Q1 EPS reported $0.10 vs consensus -$0.07 ▲ beat (+253.8%)

Record Q1 net sales of $93.5M, up 119.6% YoY, driven by China recovery and U.S. growth.
GAAP net income $5.2M ($0.10 diluted EPS) vs net loss of $54.2M ($1.10 loss) a year ago.
Adjusted EBITDA $24.4M ($0.48/share) vs adjusted EBITDA loss of $26.3M in prior year.
Gross margin improved to 73.6% from 65.8%; operating expenses down 18% YoY.
China distributor inventory normalized; EVO+ ICL launch early demand exceeded expectations.

item 2.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.